Biologics for the 21st century.
About IDT Biologika

Biotechnology for people and animals — carrying a strong tradition into the future

At IDT Biologika, we are an international leader in the field of biotechnology, a key global technology for the 21st century. Our 95-year tradition of manufacturing vaccines and pharmaceuticals motivates and obligates us to continue our work in improving the health of humans and animals, now and going forward. Today, our company ranks among the top echelon of innovative high-tech life science companies, delivering a consistent level of quality in the standardized production of biopharmaceuticals. We have achieved this position through our commitment to employing highly qualified staff, using state-of-the-art production technologies, and strongly investing in research and development.

Award-winning innovation and quality — IDT focuses on contract manufacturing for human and animal health. IDT Biologika has received international accolades for the development and manufacturing of new vaccines.

IDT Biologika inaugurates new multifunctional production facility for vaccines at BioPharmaPark area

Friday, 5. July 2019

New building for vaccine production enables even more flexible reaction to customer demands more info

Ceva completes acquisition

Wednesday, 3. July 2019

Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split more info

IDT Biologika to concentrate on human vaccines and pharmaceuticals

Wednesday, 5. June 2019

Divestment of animal health business unit enables focus on global growth market more info

Ceva Santé Animale and IDT Biologika GmbH

Friday, 17. May 2019

Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portfolio and boosting swine innovation more info

CMO Leadership Awards 2019

Tuesday, 26. March 2019

IDT Biologika Receives Six 2019 CMO Leadership Awards more info

Twitter
@IDT Biologika

Tuesday, 16. July 2019

RT @IMG_ST: Last Friday a multifunctional production facility for human virus production was inaugurated at the #Biopharmapark in #SaxonyAn… more info

Thursday, 6. June 2019

RT @iitoLifeScience: IDT Biologika to Divest Animal Health Business Unit to Focus on Production of Human Vaccines & Medicines https://t.co/… more info

Friday, 17. May 2019

RT @CevaSanteAnimal: [Press Release] 📣 Ceva is proud to announce provisional agreement to acquire the animal health business of biopharmac… more info

Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split more info

Divestment of animal health business unit enables focus on global growth market more info

Ceva Santé Animale and IDT Biologika GmbH more info

Contact & Address

IDT as employer — Jobs for the future more info